WarfarinProthrombinProthrombin TimeAnticoagulantsVitamin K Epoxide ReductasesVitamin KBlood CoagulationHypoprothrombinemiasFactor VPartial Thromboplastin TimeFactor XaThromboembolismFactor XHemorrhageBlood Coagulation FactorsBlood Coagulation TestsThrombophiliaFactor VaThrombinBlood Coagulation DisordersVitamin K DeficiencyThromboplastinAtrial Fibrillation1-Carboxyglutamic Acidbeta-AlanineMixed Function OxygenasesVitamin K 1RodenticidesInternational Normalized RatioAryl Hydrocarbon HydroxylasesProtein CFactor VIIThrombosisVenous ThrombosisPharmacogenetics4-HydroxycoumarinsCarbon-Carbon LigasesAntithrombinsHemostasisAntithrombin IIICoagulantsDrug MonitoringAcenocoumarolAspirinStrokeFibrinopeptide AFactor IXDrug InteractionsThrombin TimeFibrinogenLupus Coagulation InhibitorProtein SKringlesPeptide FragmentsDisseminated Intravascular CoagulationHirudinsFibrin Fibrinogen Degradation ProductsThrombophlebitisPhospholipidsIntracranial HemorrhagesEnzyme PrecursorsAdministration, OralPhosphatidylserinesHeparinBenzimidazolesKineticsDrug Dosage CalculationsHemorrhagic DisordersCattleProtein PrecursorsRisk FactorsActivated Protein C ResistanceVenous ThromboembolismDose-Response Relationship, DrugFibrinolysisFactor VIIaFibrinolytic AgentsSnake VenomsHeparin, Low-Molecular-WeightDicumarolDansyl CompoundsTreatment OutcomeGenotypePlatelet Aggregation InhibitorsAntibodies, AntiphospholipidEmbolismTime FactorsPlasmaAntithrombin ProteinsFactor X DeficiencyProtein BindingPulmonary EmbolismRetrospective StudiesHerb-Drug InteractionsProspective StudiesThrombelastographyElapid VenomsBinding SitesRodent ControlThiophenes